Results 121 to 130 of about 83,877 (250)

Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study.

open access: yesJournal of Neurology Neurosurgery & Psychiatry, 2019
C. Verboon   +19 more
semanticscholar   +1 more source

IVIg for Treatment of Severe Refractory Heparin‐Induced Thrombocytopenia

open access: yesChest, 2017
A. Padmanabhan   +13 more
semanticscholar   +1 more source

Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice

open access: yesNeurotherapeutics, 2019
M. Dimitriadou   +4 more
semanticscholar   +1 more source

Sarcoidosis-associated small fiber neuropathy in a large cohort: Clinical aspects and response to IVIG and anti-TNF alpha treatment.

open access: yesRespiratory Medicine, 2017
J. Tavee   +5 more
semanticscholar   +1 more source

Intravenous versus subcutaneous immunoglobulin in patients with haematological malignancies: time-driven activity-based costing. [PDF]

open access: yesSupport Care Cancer
de Albornoz SC   +16 more
europepmc   +1 more source

New perspectives on fetal and neonatal alloimmune thrombocytopenia for obstetricians. [PDF]

open access: yesFront Immunol
Zhao Y   +6 more
europepmc   +1 more source

POTENTIAL IMPACTS OF PHARMACEUTICAL USES OF TRANSGENIC TOBACCO: THE CASE OF HUMAN SERUM ALBUMIN (HSA) [PDF]

open access: yes
The potential size and distribution of benefits from transgenic tobacco as a source of human serum albumin are estimated using an economic surplus model with imperfect competition.
Kostandini, Genti   +2 more
core   +1 more source

Safety assessment of intravenous immunoglobulins in pediatric population: A systematic review of adverse events. [PDF]

open access: yesMedicine (Baltimore)
Altowairqi M   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy